
New Cancer Vaccine Cuts Melanoma Risk by Nearly Half
A groundbreaking mRNA therapy reduced melanoma recurrence or death by 49% over five years when combined with immunotherapy. The personalized vaccine teaches patients' immune systems to recognize and attack their specific cancer cells.
















